Support and guidance for retail stores
Fimea’s objective is to ensure that the sale of non-prescription medicines is carried out safely, equally and in compliance with regulations. These web pages compile information to support the guidance and supervision of retail sale points for non-prescription medicines outside pharmacies.
Fimea responds to questions related to the expansion of sales channels for non prescription medicines on the FAQ page for the retail sale of non-prescription medicines as well as via the service email ([email protected]). The responsibilities of retail stores are described in more detail on a dedicated subpage on Fimea’s website. Instructions on applying for a retail licence will be published later in 2026.
The pages will be updated regularly during 2026 as details are further specified.
What retailer stores of non prescription medicines need to know?
- Non-prescription medicines are not ordinary consumer goods.
- Incorrect handling or use of non-prescription medicines may cause harm to people and the environment.
- Retail stores must familiarise themselves with the legislation concerning non-prescription medicines as well as the procedures related to their sale.
- Retail stores may apply to Fimea for a retail licence as of 1 January 2027. The retail licence entitles the holder to sell non-prescription medicines approved for an expanded sales channel.
- Retail stores must recognise their own role and obligations as part of the retail sale of non-prescription medicines and the pharmaceutical supply system.
- Fimea supervises the retail sale of non-prescription medicines and may, where necessary, ensure that sales are carried out in compliance with the requirements.
- Non-prescription medicines are procured through the official distribution chain, i.e. medicinal wholesalers.
- Unlike pharmacies, retailer stores of nonrescription medicines are not permitted to provide medicinal counselling.